Product Description: Dextran sulfate sodium salt (DSS) (MW 6500-10000) is a polymer of dehydrated glucose with a molecular weight of approximately 5000. Dextran sulfate sodium salt with different molecular weights exhibits different biological activities. Dextran sulfate sodium salt (MW 6500-10000) has antiviral activity against HIV-1 and HIV-2. Dextran sulfate sodium salt (MW 6500-10000) blocks the binding of virions to CD4⁺ T lymphocytes and inhibits syncytia formation. Dextran sulfate sodium salt (MW 6500-10000) also prevents experimental urolithiasis due to its cytoprotective actions. Moreover, because of its biocompatible and highly charged properties, Dextran sulfate sodium salt (MW 6500-10000) is a suitable choice for pharmaceutical systems[1][2][3][4][5][6].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]1.Mitsuya H, et al. Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells. Science. 1988 Apr 29;240(4852):646-9./[2]2.Tostes V, et al. Low-molecular-weight dextran sulfate prevents experimental urolithiasis in rats. Clin Chim Acta. 2004 Mar;341(1-2):147-55. /[3]3.Lu G, et al. Dextran Sulfate Protects Pancreatic β-Cells, Reduces Autoimmunity, and Ameliorates Type 1 Diabetes. Diabetes. 2020 Aug;69(8):1692-1707. /[4]4.Tu C, et al. Paramagnetic, silicon quantum dots for magnetic resonance and two-photon imaging of macrophages. J Am Chem Soc. 2010 Feb 17;132(6):2016-23. /[5]5.Diego Carballares, et al. Preparation of a Six-Enzyme Multilayer Combi-Biocatalyst: Reuse of the Most Stable Enzymes after Inactivation of the Least Stable One. ACS Sustainable Chemistry & Engineering. 10 (1). /[6]6.Gui Z, et al. Prolonged melittin release from polyelectrolyte-based nanocomplexes decreases acute toxicity and improves blood glycemic control in a mouse model of type II diabetes. Int J Pharm. 2020 Mar 15;577:119071.
CAS Number: 9011-18-1
Molecular Weight: 6500-10000
Research Area: Inflammation/Immunology
Target: HIV
English
Deutsch
